Clinical Trials Logo

Clinical Trial Summary

A double-blind, randomized, controlled trial was conducted with the main objective of evaluating if patients with clinical assessment and VExUS reach decongestion faster within a maximum period of 7 days during the hospital stay. Likewise, the study will describe those patients who experience a decrease in serum creatinine (CrS), NT-proBNP at discharge, greater diuretic adjustment, rate of intrahospital readmission, and 30-day mortality.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06065163
Study type Interventional
Source Instituto Nacional de Cardiologia Ignacio Chavez
Contact Salvador López Gil, MD
Phone 5555732911
Email salvadorlgil@gmail.com
Status Recruiting
Phase N/A
Start date September 1, 2022
Completion date March 31, 2025